| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/04/2002 | US6399389 High throughput screening assay systems in microscale fluidic devices |
| 06/04/2002 | US6399381 Mixture of inorganic salts, amino acids, amine, vitamin c, dexamethasone, calcium salt, retinoic acid, triiodothyronine, hydrocortisone, pituitary gland extract, transferrins and epidermal growth factor |
| 06/04/2002 | US6399378 Antisense modulation of RECQL2 expression |
| 06/04/2002 | US6399374 A rodent-human cell line which maintains its human chromosomal content after 90 generations |
| 06/04/2002 | US6399373 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid |
| 06/04/2002 | US6399364 A method to analyze nucleic acid sequences using a mixture of labelled oligonucleotides in a solution with immobilized oligonucleotides; incubate target nucleic acids with labelled oligonucleotide; the hybridized mixtures are then recovered |
| 06/04/2002 | US6399356 Process and agent for sanitation of contaminations caused by viruses |
| 06/04/2002 | US6399350 Screening for modulators by exposing kuz polypeptide to protease substrate in presence of modulating agent which can be an antibody, dominant negative fragment of the polypeptide or enzyme inhibitor |
| 06/04/2002 | US6399348 DNA sequences for matrix metalloproteases, their production and use |
| 06/04/2002 | US6399337 Culturing host cell modified by polynucleotide encoding the enzyme of defined amino acid sequence, then host cell with substrate suitable to produce a fucosylated oligosaccharide |
| 06/04/2002 | US6399334 Calibration of nucleotide sequences; generate preferential nucleotide sequences, incubate with hapten, remove and evaluate hybridized nucleotide sequences |
| 06/04/2002 | US6399330 Nucleotide and amino acid sequences of crystal/insecticidal proteins; active against japanese beetle and red flour beetle; biological pest control |
| 06/04/2002 | US6399328 Amino acid sequence; hybridization probes; amplification primers; anticarcinogenic agents; antitumor agents |
| 06/04/2002 | US6399326 Nucleic acid which encodes polypeptide of defined amino acid sequence which has a cysteine motif |
| 06/04/2002 | US6399321 Methods for screening UDP-glucose:glycoprotein glucosyltransferase (UGGT) activity and nucleic acid encoding for UGGT |
| 06/04/2002 | US6399319 Protein kinase assay as a method for identification of fungicides |
| 06/04/2002 | US6399315 Drug screening by contacting cells transfected with nucleic acid encoding a g-protein coupled receptor which binds corticotropin-releasing factor, then monitoring cell for compounds which bind the receptor |
| 06/04/2002 | US6399312 Myostatin gene promoter and inhibition of activation thereof |
| 06/04/2002 | US6399311 Subjecting a vascular endothelial cell to hydrodynamic stress, assessing the level of gene expression, comparing with the expression of the same gene on a second cell subjected to different hydrodynamic stress; atherosclerosis |
| 06/04/2002 | US6399310 Administering mirtazapine to patients which are carriers for apolipoprotein e4 gene |
| 06/04/2002 | US6399309 Amplification and detection of mycoplasma pneumoniae targeting the ORF9 region of the hmw gene cluster |
| 06/04/2002 | US6399308 Rupestris stem pitting associated virus nucleic acids, proteins, and their uses |
| 06/04/2002 | US6399307 Obtaining sample from animal, isolating rna, using ribonuclease resistant standard encapsidated in viral coat protein, and analyzing for presence of indicator sequence |
| 06/04/2002 | US6399306 Identifying hypertensive patients having allele or genotype at lipoprotein lipase gene restriction sites, angiotensin converting enzyme gene insertion site or angiotensinogen mutation site, then engaging patient in exercise |
| 06/04/2002 | US6399305 Protection of partial complementary nucleic acid fragment using a electroconductive chip and intercalator |
| 06/04/2002 | US6399304 Sequential activation of one or more enzymatic activities within a thermocycling reaction for synthesizing DNA molecules |
| 06/04/2002 | US6399303 High resolution DNA detection methods and devices |
| 06/04/2002 | US6399302 Using compound having acceptor fluorophore and donor fluorophore attatched to aptamers which in turn are joined together through a linker |
| 06/04/2002 | US6399300 Recombinant embryonic cardiomyocyte cell having two constructs which are selectable marker genes under control of separate promoters; gene therapy; drug screening |
| 06/04/2002 | US6399299 Has a reporter system that is independent of layering |
| 06/04/2002 | US6399298 Ku70—related methods |
| 06/04/2002 | US6399297 Antisense modulation of expression of tumor necrosis factor receptor-associated factors (TRAFs) |
| 06/04/2002 | US6399296 Detecting specific protein in sample by contacting with second protein having reduced structural flexibility due to recombinantly introduced disulfide bonding, allowing proteins to complex, then detecting complex |
| 06/04/2002 | US6399294 Probes; primers; immunogens; for diagnosis of human immunodeficiency virus infections |
| 06/04/2002 | US6399148 Multilayer structure; metallic layer, dielectric, resistor and connector |
| 06/04/2002 | US6399112 Chinese herbs extract |
| 06/04/2002 | US6399066 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/04/2002 | US6399065 Methods for modulating SLAM-expressing T cells |
| 06/04/2002 | CA2364294A1 Testing endosymbiont cellular organelles and compounds identifiable therewith |
| 06/04/2002 | CA2095495C Assay for serum cholinesterase |
| 06/04/2002 | CA1341365C Analyte detecting composition utilizing polynucleotide sequences |
| 05/30/2002 | WO2002042842A2 A high-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels |
| 05/30/2002 | WO2002042776A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042775A2 Clinically intelligent diagnostic devices and methods |
| 05/30/2002 | WO2002042771A2 Detection of binding reactions using catalytic electrochemical labels |
| 05/30/2002 | WO2002042770A1 Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same |
| 05/30/2002 | WO2002042767A2 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium |
| 05/30/2002 | WO2002042764A1 Materials for enhancing staining of biopolymers in matrices |
| 05/30/2002 | WO2002042735A2 Human kcr1 regulation of herg potassium channel block |
| 05/30/2002 | WO2002042732A2 A method to measure the activation state of signaling pathways in cells |
| 05/30/2002 | WO2002042500A2 Apparatus and method for electrophoretic microspot concentration |
| 05/30/2002 | WO2002042498A2 Dual bead assays including optical biodiscs and methods relating thereto |
| 05/30/2002 | WO2002042497A2 Methods using fluorescens energy transfer probes for detecting cleavage of nucleic acids |
| 05/30/2002 | WO2002042496A2 Methods and devices for characterizing duplex nucleic acid molecules |
| 05/30/2002 | WO2002042495A2 Method of screening eukaryotes |
| 05/30/2002 | WO2002042494A1 Method of quantifying hiv-1 rna-dna hybrid and diagnosis kit |
| 05/30/2002 | WO2002042493A1 Method of testing anticancer agent-sensitivity of tumor cells |
| 05/30/2002 | WO2002042492A2 Method for detecting protozoae of the genus naegleria |
| 05/30/2002 | WO2002042490A1 Method of optimising the sequences of synthetic nucleic acids |
| 05/30/2002 | WO2002042489A1 Methods involving a t cell protein tyrosine phosphatase |
| 05/30/2002 | WO2002042488A1 Detection of infections in liquid samples by detecting fatty acids present in the headspace associated with the liquid sample |
| 05/30/2002 | WO2002042486A2 Methods for detection of a nucleic acid by sequential amplification |
| 05/30/2002 | WO2002042485A2 Methods and computer software products for selecting nucleic acid probes |
| 05/30/2002 | WO2002042470A1 Isolated luciferases and the use thereof |
| 05/30/2002 | WO2002042469A1 Isolated luciferases lu164, lual and lu22, and the use of the same |
| 05/30/2002 | WO2002042460A2 Compositions and methods relating to colon specific genes and proteins |
| 05/30/2002 | WO2002042456A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042445A2 Differentiated cells suitable for human therapy |
| 05/30/2002 | WO2002042444A2 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | WO2002042442A2 Yeast strain for consumption |
| 05/30/2002 | WO2002042440A2 Regulation of plant growth by modifying the expression of a putative trna-isope ntenyl transferase |
| 05/30/2002 | WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | WO2002042436A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 05/30/2002 | WO2002042432A2 Epothilone resistant cell lines |
| 05/30/2002 | WO2002042417A2 Human erg2 potassium channel |
| 05/30/2002 | WO2002042410A2 Process for trapping and confining microorganisms in air using water-soluble polymers |
| 05/30/2002 | WO2002042330A2 Cystoskeleton-associated proteins |
| 05/30/2002 | WO2002042328A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 05/30/2002 | WO2002042324A1 Gene encoding protein cluster i and the encoded protein |
| 05/30/2002 | WO2002042316A2 Pna analogues |
| 05/30/2002 | WO2002041973A1 Separating living particles of a gas under pressure |
| 05/30/2002 | WO2002041906A2 Methods and apparatus for producing gender enriched sperm |
| 05/30/2002 | WO2002041836A2 Antisense modulation of src-1 expression |
| 05/30/2002 | WO2002022649A3 Screening methods to identify g-proteins and other compounds which modulate phosphodiesterase (pde) activity |
| 05/30/2002 | WO2002022648A3 Compositions and methods for inducing specific cytolytic t cell responses |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002018581A9 G-protein coupled receptors |
| 05/30/2002 | WO2002018441A3 Electroprocessed fibrin-based matrices and tissues |
| 05/30/2002 | WO2002018438A9 Modified proteins, isolated novel peptides, and uses thereof |
| 05/30/2002 | WO2002016903A3 Microfluidic device and method with trapping of sample in carities having lids that can be opened or closed |
| 05/30/2002 | WO2002014476A3 Identifying and quantifying rnas and dnas associated with rna and dna binding proteins |
| 05/30/2002 | WO2002003062A3 Whole blood assay method |
| 05/30/2002 | WO2002002807A8 Diagnosis of diseases associated with cell signalling |
| 05/30/2002 | WO2002002756A3 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 05/30/2002 | WO2002002738A3 Host cells containing multiple integrating vectors |
| 05/30/2002 | WO2002000675A3 Haplotypes of the hnf3a gene |
| 05/30/2002 | WO2002000254A3 Materials and methods relating for the treatment and diagnosis of pre-eclampsia |
| 05/30/2002 | WO2001098534A3 Matrix screening method |
| 05/30/2002 | WO2001094632A3 Highly sensitive gene detection and localization using in situ branched-dna hybridization |